AnaptysBio, Inc. (ANAB)
NASDAQ·Healthcare·Biotechnology
$46.61
+0.34%
Mkt Cap $1.44B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (35 analysts)
$79.17
Range $70.00 – $95.00
Implied Upside
+69.9%
Consensus $79.17 vs current $46.61
NASDAQ·Healthcare·Biotechnology
$46.61
+0.34%
Mkt Cap $1.44B
Buy
7
Hold
0
Sell
0
Price Target (35 analysts)
$79.17
Range $70.00 – $95.00
+69.9%
Consensus $79.17 vs current $46.61